Dual regulation of gastrointestinal tumor progression by the IFN-γ/STAT1 pathway and prospects for targeted therapy.

However, pembrolizumab alone improved overall survival compared to chemotherapy alone in patients with CPS ≥10, although the difference did not reach statistical significance ( 189 ).

also in 111,027 other papers